Size exclusion chromatography with evaporative light scattering detection as a method for speciation analysis of polydimethylsiloxanes. II. Validation of the method for analysis of pharmaceutical formulations

被引:10
作者
Mojsiewicz-Pienkowska, Krystyna [1 ]
机构
[1] Med Univ Gdansk, Fac Pharm, Dept Phys Chem, PL-80416 Gdansk, Poland
关键词
Dimeticone; Simeticone; Size exclusion chromatography; Evaporative light scattering detector; Validation of method with acceptance criteria; SILICONE OIL; MOLECULAR-WEIGHT; CRITERIA;
D O I
10.1016/j.jpba.2011.07.021
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The aim of this study was to demonstrate the usefulness of the size exclusion chromatography with evaporative light scattering detection (SEC-ELSD) method in the identification and quantitative analysis of polydimethylsiloxanes (PDMS). The process of validation for the method was conducted, and the values obtained were compared with the acceptance criteria. Particularly important was the conclusion that SEC-ELSD method showed a high specificity for PDMS. PDMS is an organosilicon polymer and for this reason, it does not exist as a concrete chemical species. Depending on the length of the chain, PDMS can be toxic for organism. So far, the SEC-ELSD method has not been applied for the control of pharmaceutical products containing such PDMS as dimeticone or simeticone. The safety of use and effectiveness of such pharmaceutical products relies on the control of their quality. Therefore, the analytical methods and procedures that meet acceptance criteria for qualitative and quantitative analysis of the PDMS should be used. In the case of the analysis of pharmaceutical products, the acceptance criteria are established and recommended by, for example, the Pharmacopoeias, the U.S. Food and Drug Administration (FDA), the International Conference on Harmonisation (ICH) and the World Health Organization (WHO). The progress of knowledge, however, requires the development of new analytical tools which are able to solve incoming problems. In the case of pharmaceutical formulations containing PDMS, which are used not only by adults but also by children, it is necessary to use analytical methods which are characterized by a high specificity. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:851 / 858
页数:8
相关论文
共 26 条
[1]  
[Anonymous], 2005, INT C HARM TECHN REQ
[2]  
Bliesner DM., 2006, VALIDATING CHROMATOG
[3]   Migration of silicone oil into the brain: A complication of intraocular silicone oil for retinal tamponade [J].
Eller, AW ;
Friberg, TR ;
Mah, F .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 129 (05) :685-688
[4]   Validation in pharmaceutical analysis - Part II: central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data [J].
Ermer, J ;
Ploss, HJ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (05) :859-870
[5]  
Ermer J, 2005, METHOD VALIDATION IN PHARMACEUTICAL ANALYSIS: A GUIDE TO BEST PRACTICE, P1
[6]   Validation in pharmaceutical analysis. Part I: An integrated approach [J].
Ermer, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 24 (5-6) :755-767
[7]  
HAIDER SI, 2006, STEP BY STEP GUIDE A
[8]  
Huber L., 2007, Validation and Qualification in Analytical Laboratories, VSecond
[9]   Harmonization of strategies for the validation of quantitative analytical procedures - A SFSTP proposal - Part II [J].
Hubert, Ph. ;
J.-J., Nguyen-Huu ;
Boulanger, B. ;
Chapuzet, E. ;
Chiap, P. ;
Cohen, N. ;
Compagnon, P.-A. ;
Dewe, W. ;
Feinberg, M. ;
Lallier, M. ;
Laurentie, M. ;
Mercier, N. ;
Muzard, G. ;
Nivet, C. ;
Valat, L. ;
Rozet, E. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 45 (01) :70-81
[10]  
Iribarren P., 2002, BMC IMMUNOL, V3, P1